CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Phase II and Biomarker Study of the Dual MET/VEGFR2 Inhibitor Foretinib in Patients With Papillary Renal Cell Carcinoma
Authors
Andrea L. Harzstark
Brian I. Rini
+26Â more
David F. McDermott
Delahunt B
Donald P. Bottaro
Jonathan E. Rosenberg
Keith T. Flaherty
Kevin H. Laubscher
Laurel M. Adams
Laurie Sherman
Lone H. Ottesen
Maria J. Merino
Mark N. Stein
Naomi B. Haas
Paul S. Meltzer
Peter Eisenberg
Ramaprasad Srinivasan
Ravaud A
Robert Ross
Ronald M. Bukowski
Sandy Srinivas
Schutz FA
Shapiro GI
Tannir NM
Theodore F. Logan
Toni K. Choueiri
Ulka Vaishampayan
W. Marston Linehan
Publication date
Publisher
'American Society of Clinical Oncology (ASCO)'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1200%2Fjco.2012.43...
Last time updated on 02/01/2020